These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1274 related articles for article (PubMed ID: 27449032)

  • 1. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
    Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
    Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evodiamine Exerts an Anti-Hepatocellular Carcinoma Activity through a WWOX-Dependent Pathway.
    Hu CY; Wu HT; Su YC; Lin CH; Chang CJ; Wu CL
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28708106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
    Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
    J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor effect of evodiamine by inducing Akt-mediated apoptosis in hepatocellular carcinoma.
    Yang F; Shi L; Liang T; Ji L; Zhang G; Shen Y; Zhu F; Xu L
    Biochem Biophys Res Commun; 2017 Mar; 485(1):54-61. PubMed ID: 28189683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
    Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
    Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epigallocatechin gallate derivative Y
    Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
    J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Y-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model.
    Siveen KS; Ahn KS; Ong TH; Shanmugam MK; Li F; Yap WN; Kumar AP; Fong CW; Tergaonkar V; Hui KM; Sethi G
    Oncotarget; 2014 Apr; 5(7):1897-911. PubMed ID: 24722367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts.
    Jia WD; Xu GL; Xu RN; Sun HC; Wang L; Yu JH; Wang J; Li JS; Zhai ZM; Xue Q
    J Cancer Res Clin Oncol; 2003 Jun; 129(6):327-34. PubMed ID: 12811549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor.
    Jung KH; Zheng HM; Jeong Y; Choi MJ; Lee H; Hong SW; Lee HS; Son MK; Lee S; Hong S; Hong SS
    Cancer Lett; 2013 Jan; 328(1):176-87. PubMed ID: 22902995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma.
    Guo P; Wang Y; Dai C; Tao C; Wu F; Xie X; Yu H; Zhu Q; Li J; Ye L; Yu F; Shan Y; Yu Z; Dhanasekaran R; Zheng R; Chen G
    Oncogene; 2018 Mar; 37(9):1220-1236. PubMed ID: 29242604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evodiamine inhibits in vitro angiogenesis: Implication for antitumorgenicity.
    Shyu KG; Lin S; Lee CC; Chen E; Lin LC; Wang BW; Tsai SC
    Life Sci; 2006 Apr; 78(19):2234-43. PubMed ID: 16280136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.
    Chai ZT; Kong J; Zhu XD; Zhang YY; Lu L; Zhou JM; Wang LR; Zhang KZ; Zhang QB; Ao JY; Wang M; Wu WZ; Wang L; Tang ZY; Sun HC
    PLoS One; 2013; 8(10):e77957. PubMed ID: 24194905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic and antihepatocellular carcinoma activities of the Juniperus chinensis extract.
    Kuo ZK; Lin MW; Lu IH; Yao HJ; Wu HC; Wang CC; Lin SH; Wu SY; Tong TS; Cheng YC; Yen JH; Ko CH; Chiou SJ; Pan IH; Tseng HW
    BMC Complement Altern Med; 2016 Aug; 16():277. PubMed ID: 27502492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
    Fan Y; Peng A; He S; Shao X; Nie C; Chen L
    J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
    Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
    Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
    Han D; Cao C; Su Y; Wang J; Sun J; Chen H; Xu A
    J Ethnopharmacol; 2016 Nov; 192():406-412. PubMed ID: 27649680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma.
    Yang C; Qin S
    Cancer Med; 2018 Sep; 7(9):4570-4583. PubMed ID: 30109780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
    Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
    Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solanum nigrum Suppress Angiogenesis-Mediated Tumor Growth Through Inhibition of the AKT/mTOR Pathway.
    Yang MY; Hung CH; Chang CH; Tseng TH; Wang CJ
    Am J Chin Med; 2016; 44(6):1273-1288. PubMed ID: 27627922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signaling.
    Bai XL; Zhang Q; Ye LY; Liang F; Sun X; Chen Y; Hu QD; Fu QH; Su W; Chen Z; Zhuang ZP; Liang TB
    Oncogene; 2015 Jul; 34(31):4089-97. PubMed ID: 25328135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.